GAM
GILD icon

Gould Asset Management’s Gilead Sciences GILD Stock Holding History

Gould Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,834
Closed -$287K – 135
2020
Q1 		$287K Buy
+3,834
New +$265K 0.11% 92
2018
Q3 		– Sell
-3,400
Closed -$241K – 145
2018
Q2 		$241K Sell
3,400
-411
-11% -$29K 0.1% 111
2018
Q1 		$287K Buy
+3,811
New +$303K 0.13% 94

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Gould Asset Management's GILD Position: Q2 2020 in Review

Gould Asset Management sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 3,834 shares — an estimated $287K sold.

Gould Asset Management first reported a position in GILD in Q1 2018 and held it in 3 quarters. The position peaked at $287K in Q1 2020. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Gould Asset Management reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Gould Asset Management sold 3,834 Gilead Sciences shares in Q2 2020, an estimated $287K.
  • Gould Asset Management first reported a position in Gilead Sciences in Q1 2018 and held it in 3 quarters.
  • Gould Asset Management's Gilead Sciences position peaked at $287K in Q1 2020.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Gould Asset Management's 13F filing for Q2 2020, filed 5 Aug 2020.